Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients

Pediatric Blood and Cancer

Volumn 49, Issue 5, 2007, Pages 656-660

  Yu, Jennifer ^a   Chou, Alexander J ^b   Lennox, Alison ^b   Kleiman, Phillip ^b   Wexler, Leonard H ^b   Meyers, Paul A ^b   Gorlick, Richard ^c  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

Author keywords

Chemotherapy; Immunization; Pediatric sarcoma

Indexed keywords

CHICKENPOX VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; MUMPS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; TETANUS TOXOID; ANTIBODY; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CANCER CHEMOTHERAPY; CHICKENPOX; CHILD; CHILDHOOD CANCER; EWING SARCOMA; FEMALE; HEPATITIS B; HUMAN; INFECTION COMPLICATION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; OSTEOSARCOMA; POLIOMYELITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVACCINATION; RHABDOMYOSARCOMA; RUBELLA; TETANUS; VACCINATION; DRUG EFFECT; OPPORTUNISTIC INFECTION; SARCOMA; STANDARD;

ADOLESCENT; ANTIBODIES; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; OPPORTUNISTIC INFECTIONS; OSTEOSARCOMA; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA; SARCOMA; SARCOMA, EWING'S; VACCINATION;

EID: 35148853087     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21277     Document Type: Article

References (20)

1. Ljungman P, Cordonnier C, de Bock R, et al. Immunisations after bone marrow transplantation: Results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1995;15:455-460.
2. Mahajan A, English MW, Jenney ME, et al. Survey of immunisation practices in the United Kingdom during and following completion of anti-cancer chemotherapy in children. Med Pediatr Oncol 2003;40:270-271.
3. Fioredda F, Plebani A, Hanau G, et al. Re-immunisation schedule in leukaemic children after intensive chemotherapy: A possible strategy. Eur J Haematol 2005;74:20-23.
4. Zignol M, Peracchi M, Tridello G, et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer 2004;101:635-641.
5. Sone S, Taoka S, Yata K, et al. Phytohemagglutinin skin test: Diagnostic value for showing immunodeficiency in patients with cancer. Gann 1975;66:641-648.
6. Kolb EA, Kushner BH, Gorlick R, et al. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol 2003;21:3423-3430.
7. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348: 694-701.
8. Alanko S, Pelliniemi TT, Salmi TT. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992;69:1481-1486.
9. Mackall CL. T-cell immunodeficiency following cytotoxic antineoplastic therapy: A review. Stem Cells (Dayton, Ohio) 2000;18: 10-18.
10. Centers for Disease Control and Prevention. Impact of vaccines universally recommended for children-United States, 1990-1998. MMWR Morb Mortal Wkly Rep 1999;48:243-248.
11. Toubi E, Etzioni A. Intravenous immunoglobulin in immunodeficiency states: State of the art. Clin Rev Allergy Immunol 2005; 29:167-172.
12. Nilsson A, De Milito A, Engstrom P, et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 2002; 109:e91.
13. Ayerbe MC, Perez-Rivilla A. Assessment of long-term efficacy of hepatitis B vaccine. Eur J Epidemiol 2001;17:150-156.
14. Barash C, Conn MI, DiMarino AJ Jr, et al. Serologic hepatitis B immunity in vaccinated health care workers. Arch Intern Med 1999;159:1481-1483.
15. McMahon BJ, Bruden DL, Petersen KM, et al. Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up. Ann Intern Med 2005;142:333-341.
16. Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 2001;20:63-75.
17. Yuen MF, Lim WL, Chan AO, et al. 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. Clin Gastroenterol Hepatol 2004;2:941-945.
18. Bellier B, Thomas-Vaslin V, Saron MF, et al. Turning immunological memory into amnesia by depletion of dividing T cells. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100:15017-15022.
19. Heitger A, Winklehner P, Obexer P, et al. Defective T-helper cell function after T-cell-depleting therapy affecting naive and memory populations. Blood 2002;99:4053-4062.
20. von der Hardt K, Jungert J, Beck JD, et al. Humoral immunity against diphtheria, tetanus and poliomyelitis after antineoplastic therapy in children and adolescents - A retrospective analysis. Vaccine 2000;18:2999-3004.